CBX8 and cervical cancer: Postoperative overall survival (OS) of patients with cervical cancer with high CBX8 expression was shorter (P = .005; Fig. 3A) than that of patients with low CBX8 expression, and the 5-year survival rate of the 2 groups was 60.3% and 82.5%, respectively.